Treatment of children living with HIV
WHO
An estimated 3.2 million children were living with HIV at the end of 2013, mostly in sub-Saharan Africa. Majority of them acquire HIV from their HIV-infected mothers during pregnancy, birth or breastfeeding. With efficacious interventions the risk of mother-to-child HIV transmission can be reduced to 2%. However, such interventions are still not widely accessible or available in most resource-limited countries where the burden of HIV is highest. And these children who are already infected with HIV need to be enrolled in effective treatment to stay healthy.
Latest updates
-
Pediatric treatment scale-up: the unfinished agenda of the Global Plan
May 2017 -
Scale-up of early infant HIV diagnosis and improving access to pediatric HIV care in Global Plan countries: past and future perspectives
May 2017 -
Translating technical support into country action: the role of the Interagency Task Team On The Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children in the Global Plan era
May 2017 -
Making the right drugs available for children with HIV
Paediatrics Week on drug optimization - 5-9 December 2016 -
Clinical impact and cost-effectiveness of early infant HIV diagnosis in South Africa: test timing and frequency
Journal article - September 2016 -
Share your view: research priorities for paediatric and adolescent HIV
September 2016 -
WHO confirms antiretroviral therapy reduces the risk of life-threatening HIV-related infections
June 2016